Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003

AUTOR(ES)

Farrell, David J.

FONTE

American Society for Microbiology

RESUMO

Telithromycin MICs for 13,874 Streptococcus pneumoniae isolates collected in the first 3 years of the global PROTEKT study (1999 to 2003) were studied. There was no change in the distribution of telithromycin MICs over this period, even in countries where telithromycin is in use. The telithromycin MICs for 10 isolates (0.07%) were ≥4 μg/ml, and these 10 isolates contained erm(B); there was no evidence of reproducible clonal spread between centers.

Documentos Relacionados

• Activities of Cethromycin and Telithromycin against Recent North American Isolates of Streptococcus pneumoniae
• In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms
• Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections
• In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations
• In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.